NO20052037L - Doseringsformer med to kjerner og en apning med modifisert frigivelse - Google Patents
Doseringsformer med to kjerner og en apning med modifisert frigivelseInfo
- Publication number
- NO20052037L NO20052037L NO20052037A NO20052037A NO20052037L NO 20052037 L NO20052037 L NO 20052037L NO 20052037 A NO20052037 A NO 20052037A NO 20052037 A NO20052037 A NO 20052037A NO 20052037 L NO20052037 L NO 20052037L
- Authority
- NO
- Norway
- Prior art keywords
- cores
- modified release
- dosage forms
- release aperture
- opening
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2002/031129 WO2003026630A1 (en) | 2001-09-28 | 2002-09-28 | Dosage forms having an inner core and outer shell with different shapes |
PCT/US2002/031024 WO2003026625A1 (en) | 2001-09-28 | 2002-09-28 | Modified release dosage forms |
PCT/US2002/031163 WO2003026627A1 (en) | 2001-09-28 | 2002-09-28 | Composite dosage forms |
PCT/US2002/031062 WO2003026626A2 (en) | 2001-09-28 | 2002-09-28 | Modified release dosage forms |
PCT/US2002/031117 WO2003026629A2 (en) | 2001-09-28 | 2002-09-28 | Modified release dosage forms |
PCT/US2003/008894 WO2004028508A1 (en) | 2002-09-28 | 2003-03-21 | Modified release dosage forms with two cores and an opening |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20052037L true NO20052037L (no) | 2005-06-22 |
Family
ID=35276283
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20052037A NO20052037L (no) | 2002-09-28 | 2005-04-26 | Doseringsformer med to kjerner og en apning med modifisert frigivelse |
NO20052036A NO20052036L (no) | 2002-09-28 | 2005-04-26 | Doseringsform med to kjerner med modifisert frigivelse |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20052036A NO20052036L (no) | 2002-09-28 | 2005-04-26 | Doseringsform med to kjerner med modifisert frigivelse |
Country Status (2)
Country | Link |
---|---|
MX (3) | MXPA05003282A (es) |
NO (2) | NO20052037L (es) |
-
2003
- 2003-03-21 MX MXPA05003282A patent/MXPA05003282A/es not_active Application Discontinuation
- 2003-03-21 MX MXPA05003281A patent/MXPA05003281A/es active IP Right Grant
- 2003-03-21 MX MXPA05003279A patent/MXPA05003279A/es unknown
-
2005
- 2005-04-26 NO NO20052037A patent/NO20052037L/no not_active Application Discontinuation
- 2005-04-26 NO NO20052036A patent/NO20052036L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO20052036L (no) | 2005-06-22 |
MXPA05003279A (es) | 2005-11-23 |
MXPA05003281A (es) | 2005-11-23 |
MXPA05003282A (es) | 2005-11-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20062513L (no) | Sammensetninger og doseringsformer for forsterket absorpsjon av metformin | |
NO20042161L (no) | Inhibitorer av 11-beta-hydroksysteroid dehydrogenase type 1 | |
NO20025601D0 (no) | Arylmetylaminderivater for anvendelse som tryptaseinhibitorer | |
NO20054072L (no) | Terapeutisk middel for ryggmargsskade omfattende interleukin-6 antagonist. | |
NO20014986D0 (no) | 4,5-diaryl-3(2H)-furanonderivater som cyklooksygenase-2- inhibitorer | |
NO20080284L (no) | Cannabionoid aktiv farmasoytisk ingrediens for forbedrede doseringsformer | |
DK1363608T3 (da) | Formuleringer omfattende ibuprofen og diphenhydramin og deres anvendelse til behandling af sovnforstyrrelser | |
EP1599213A4 (en) | CELL MEMBRANE TRANSLOCATION OF SNARE R GUL S INHIBITORS, ASSOCIATED COMPOSITIONS AND PATHOLOGY TREATMENT PROCESSES | |
YU39800A (sh) | Derivati sulfonamida kao pro-lekovi inhibitora aspartil proteaze | |
WO2011061330A3 (de) | Verwendung physiologischer kühlwirkstoffe und mittel enthaltend solche wirkstoffe | |
DE602005007188D1 (de) | Zuckerlacton enthaltende zusammensetzung zur haarbehandlung | |
NO20042596L (no) | Inbibitorer av 11-beta-hydroksy steroid dehydrogenase type 1 | |
CR10032A (es) | Preparación sólida | |
WO2003016335A3 (en) | Irreversible cysteine protease inhibitors of legumain | |
DK1296972T3 (da) | Arylmethylamin-derivater til anvendelse som tryptaseinhibitorer | |
NO951498L (no) | Farmasöytisk preparat for behandling av osteoporose | |
NO20084276L (no) | Orodispergerbare domperidontabletter | |
NO20055367L (no) | Kombinasjoner som innbefatter paroksetin og 2-(S)-4-fluor-2-metyl-fenyl)-piperazin-1-karboksylsyer (1-(R)-(3,5-bis-trifluor-2-metyl-fenyl)-etyl]metylamid for behandling av depresjon og/eller angst | |
NO20076405L (no) | Anvendelse av 24-nor-UDCA | |
WO2005105081A3 (en) | Therapeutic formulations of desoxyepothilones | |
ATE324112T1 (de) | Topische behandlung bei der mastalgie | |
NO20073575L (no) | Farmasoytiske sammensetninger for behandling av cellulitt | |
WO2005052140A3 (en) | Multipotent postnatal stem cells from human periodontal ligament and uses thereof | |
BR0314804A (pt) | Forma de dosagem de liberação modificada | |
FR2848851B1 (fr) | Procede d'obtention d'un principe actif presentant des capacites apaisantes, principe actif et compositions obtenues |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |